Posts With Tag Arrowhead Pharmaceuticals

Showing 1 - 2 of 2 Posts

Arrowhead Pharmaceuticals 8-K Report: Key Insights & Updates

•

8-K

•

2025-02-10

Last updated: about 1 year ago

Arrowhead Pharmaceuticals 8-K Report: Key Insights & Updates

Discover Arrowhead Pharmaceuticals, Inc.'s latest 8-K filing on February 10, 2025, detailing critical updates for investors and stakeholders. Ticker: ARWR, NASDAQ.

Arrowhead Pharmaceuticals biotech NASDAQ pharmaceutical development SEC filings

Arrowhead Pharmaceuticals 8-K Report: Key Developments on December 11, 2024

•

8-K

•

2024-12-18

Last updated: about 1 year ago

Arrowhead Pharmaceuticals 8-K Report: Key Developments on December 11, 2024

Discover the latest insights from Arrowhead Pharmaceuticals' 8-K filing, detailing crucial events and updates for investors on December 11, 2024.

Arrowhead Pharmaceuticals Pharmaceuticals NASDAQ ARWR 8-K Filing Investor Relations